Murray Stahl’s Pacific Biosciences PACB Stock Holding History

Murray Stahl’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.9K	Sell	10,068 -483	-5%	-$702	﹤0.01%	339
2026 Q1	$13.9K	Sell	10,551 -483	-4%	-$864	﹤0.01%	347
2025 Q4	$20.6K	Sell	11,034 -483	-4%	-$928	﹤0.01%	321
2025 Q3	$14.7K	Buy	11,517 +483	+4%	+$654	﹤0.01%	334
2025 Q2	$13.7K	Sell	11,034 -483	-4%	-$558	﹤0.01%	350
2025 Q1	$13.6K	Hold	11,517	–	–	﹤0.01%	344
2024 Q4	$21.1K	Buy	11,517 +483	+4%	+$943	﹤0.01%	346
2024 Q3	$18.8K	Sell	11,034 -483	-4%	-$794	﹤0.01%	342
2024 Q2	$15.8K	Hold	11,517	–	–	﹤0.01%	323
2024 Q1	$43.2K	Hold	11,517	–	–	﹤0.01%	318
2023 Q4	$113K	Sell	11,517 -483	-4%	-$3.95K	﹤0.01%	306
2023 Q3	$100K	Hold	12,000	–	–	﹤0.01%	313
2023 Q2	$160K	Hold	12,000	–	–	﹤0.01%	301
2023 Q1	$139K	Hold	12,000	–	–	﹤0.01%	307
2022 Q4	$98.2K	Hold	12,000	–	–	﹤0.01%	308
2022 Q3	$70K	Hold	12,000	–	–	﹤0.01%	317
2022 Q2	$53K	Hold	12,000	–	–	﹤0.01%	327
2022 Q1	$109K	Hold	12,000	–	–	﹤0.01%	337
2021 Q4	$246K	Hold	12,000	–	–	0.01%	309
2021 Q3	$307K	Hold	12,000	–	–	0.01%	282
2021 Q2	$420K	Hold	12,000	–	–	0.01%	258
2021 Q1	$400K	Hold	12,000	–	–	0.01%	256
2020 Q4	$311K	Hold	12,000	–	–	0.01%	287
2020 Q3	$118K	Hold	12,000	–	–	﹤0.01%	354
2020 Q2	$41K	Hold	12,000	–	–	﹤0.01%	400
2020 Q1	$37K	Hold	12,000	–	–	﹤0.01%	375
2019 Q4	$62K	Hold	12,000	–	–	﹤0.01%	471
2019 Q3	$62K	Hold	12,000	–	–	﹤0.01%	475
2019 Q2	$73K	Hold	12,000	–	–	﹤0.01%	483
2019 Q1	$87K	Buy	+12,000	New	+$86.8K	﹤0.01%	476

Other funds holding PACB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Murray Stahl's PACB Position: Q2 2026 in Review

Murray Stahl reduced its Pacific Biosciences (PACB) stake by 4.6% in Q2 2026, selling an estimated $702 and leaving 10,068 shares worth $16.9K. The position accounts for ﹤0.01% of the portfolio, ranked #339.

Murray Stahl first reported a position in PACB in Q1 2019 and has held it in 30 quarters since. The position peaked at $420K in Q2 2021. 222 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

Murray Stahl held 10,068 shares of Pacific Biosciences worth $16.9K as of Q2 2026.
Murray Stahl sold 483 Pacific Biosciences shares in Q2 2026, an estimated $702.
Pacific Biosciences made up ﹤0.01% of Murray Stahl's portfolio in Q2 2026, its #339 holding.
Murray Stahl first reported a position in Pacific Biosciences in Q1 2019 and has held it in 30 quarters since.
Murray Stahl's Pacific Biosciences position peaked at $420K in Q2 2021.
222 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Horizon Kinetics Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.